Opportunities for clinical decision support targeting medication safety in remote primary care management of chronic kidney disease: A qualitative study in Northern Australia

Author:

Tan Madeleine SA1ORCID,Patel Bhavini K2,Roughead Elizabeth E3,Ward Michael3,Reuter Stephanie E3,Roberts Gregory4,Andrade Andre Q3

Affiliation:

1. Faculty of Health, Charles Darwin University, Darwin, NT, Australia

2. Medicines Management Unit, Department of Health, Northern Territory Government, Darwin, NT, Australia

3. Quality Use of Medicine and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia

4. College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia

Abstract

Introduction This study aimed to identify opportunities for clinical decision support targeting medication safety in remote primary care, by investigating the relationship between clinical workflows, health system priorities, cognitive tasks, and reasoning processes in the context of medicines used in people with chronic kidney disease (CKD). Methods This qualitative study involved one-on-one, semistructured interviews. The participants were healthcare professionals employed in a clinical or managerial capacity with clinical work experience in a remote health setting for at least 1 year. Results Twenty-five clinicians were interviewed. Of these, four were rural medical practitioners, nine were remote area nurses, eight were Aboriginal health practitioners, and four were pharmacists. Four major themes were identified from the interviews: (1) the need for a clinical decision support system to support a sustainable remote health workforce, as clinicians were “constantly stretched” and problems may “fall through the cracks”; (2) reliance on digital health technologies, as medical staff are often not physically available and clinicians-on-duty usually “flick an email and give a call so that I can actually talk it through to our GP”; (3) knowledge gaps, as “it takes a lot of mental space” to know each patient's renal function and their medication history, and clinicians believe “mistakes can be made”; and (4) multiple risk factors impacting CKD management, including clinical, social and behavioural determinants. Conclusions The high prevalence of CKD and reliance on digital health systems in remote primary health settings can make a clinical decision support system valuable for supporting clinicians who may not have extensive experience in managing medicines for people with CKD.

Funder

Digital Health CRC Limited

Publisher

SAGE Publications

Subject

Health Informatics

Reference43 articles.

1. Pharmaceutical Society of Australia. Medicine safety: Rural and remote care. Canberra: PSA; 2021.

2. Australian Commission on Safety and Quality in Health Care. Medication without harm – WHO Global Patient Safety Challenge: Australia’s response. Sydney: ACSQHC; 2020.

3. Australian Institute of Health and Welfare. Chronic kidney disease: Australian facts. 2023. https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease/contents/summary.

4. Australian Institute of Health and Welfare. Profile of First Nations people. 2023. https://www.aihw.gov.au/reports/australias-welfare/profile-of-indigenous-australians

5. Australian Institute of Health and Welfare; National Indigenous Australians Agency. Tier 1 - Health status and outcomes. 1.10 Kidney disease. 2023. https://www.indigenoushpf.gov.au/measures/1-10-kidney-disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3